Transform Wealth’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,160
Closed -$308K 222
2024
Q1
$308K Sell
4,160
-130,498
-97% -$9.1M 0.03% 183
2023
Q4
$8.9M Sell
134,658
-26,386
-16% -$1.65M 0.87% 33
2023
Q3
$10.1M Sell
161,044
-35,976
-18% -$2.24M 1.07% 24
2023
Q2
$11.1M Sell
197,020
-17,429
-8% -$967K 1% 26
2023
Q1
$12.4M Buy
214,449
+33,046
+18% +$2.23M 1.17% 28
2022
Q4
$13.1M Buy
181,403
+32,776
+22% +$2.35M 1.47% 15
2022
Q3
$9.03M Buy
148,627
+3,336
+2% +$213K 1.17% 20
2022
Q2
$9.12M Buy
+145,291
New +$9.62M 1.36% 21
2018
Q1
Sell
-98,000
Closed -$4.95M 249
2017
Q4
$4.95M Buy
+98,000
New +$5.16M 0.91% 28

Other funds holding MET

Transform Wealth's MET Position: Q2 2024 in Review

Transform Wealth sold out of MetLife (MET) in Q2 2024, closing a stake of 4,160 shares — an estimated $308K sold.

Transform Wealth first reported a position in MET in Q4 2017 and held it in 9 quarters. The position peaked at $13.1M in Q4 2022. 1,298 funds tracked by Wall St. Rank hold MET as of Q2 2024.

  • Transform Wealth reported no remaining MetLife position as of Q2 2024 after selling out during the quarter.
  • Transform Wealth sold 4,160 MetLife shares in Q2 2024, an estimated $308K.
  • Transform Wealth first reported a position in MetLife in Q4 2017 and held it in 9 quarters.
  • Transform Wealth's MetLife position peaked at $13.1M in Q4 2022.
  • 1,298 funds tracked by Wall St. Rank held MetLife as of Q2 2024.

Based on Transform Wealth's 13F filing for Q2 2024, filed 15 Jul 2024.